Community-reported Daclizumab side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Daclizumab Side Effect
Have You dealt with a Daclizumab side effect? Share your experience
Review Daclizumab Safety Reports submitted to FDA
Total Daclizumab reports: 69.Daclizumab FDA safety alerts: 2003 .
Reported deaths: 5 Reported hospitalizations: 55.
Take Daclizumab Side Effects Survey, Discuss Daclizumab with others
FDA Reported Daclizumab Side Effects: pyrexia, cardio-respiratory arrest, urinary tract infection, interstitial lung disease, enterococcal infection, escherichia infection, hepatic artery thrombosis, pneumonia, gastroenteritis viral, rash, pneumonitis.
More About Daclizumab.
If you have questions about Daclizumab, you can ask a Health Expert or Ask Patient Community about Daclizumab.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Daclizumab Side Effects Report #5612378-1
Physician from SPAIN reported DACLIZUMAB problem on Jan 22, 2008. Female patient, 62 years of age, weighting 148.8 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: herpes zoster. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SIROLIMUS, PREDNISONE, CYCLOSPORINE, OMEPRAZOLE, ATENOLOL, COTRIMOXAZOLE, TRIMETOZINE. Patient recovered.
Daclizumab Side Effects Report #5586811-8
DACLIZUMAB problem was reported by a Physician from GERMANY on Jan 04, 2008. Male patient, 66 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, leukopenia, pneumonia, renal failure, urethral stenosis, urinary retention. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5591648-X
Physician from GERMANY reported DACLIZUMAB problem on Nov 22, 2007. Male patient, 66 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, leukopenia, pneumonia, renal failure, urinary tract infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5595044-0
DACLIZUMAB problem was reported by a Health Professional from GREECE on Jan 07, 2008. Female patient, 23 years of age, was diagnosed with thrombosis prophylaxis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. DACLIZUMAB dosage: unknown. During the same period patient was treated with HEPARIN, MYCOPHENOLATE MOFETIL, ENOXAPARIN, NADROPARINE, METHYLPREDNISOLONE. Patient recovered.
Daclizumab Side Effects Report #5602618-7
Physician from GERMANY reported DACLIZUMAB problem on Nov 22, 2007. Male patient, 66 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, leukopenia, pneumonia, renal failure, urinary retention. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5609418-2
DACLIZUMAB problem was reported by a Physician from SPAIN on Jan 23, 2008. Female patient, 58 years of age, weighting 164.2 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: herpes ophthalmic, intestinal obstruction, urinary tract infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SIROLIMUS, STEROIDS NOS, PREDNISONE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5609421-2
Physician from SPAIN reported DACLIZUMAB problem on Jan 22, 2008. Male patient, 54 years of age, weighting 145.9 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, ischaemic stroke, urinary fistula, urinary tract infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, STEROIDS NOS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5551415-X
DACLIZUMAB problem was reported by a Physician from GERMANY on Dec 04, 2007. Male patient, 51 years of age, weighting 152.1 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, arterial haemorrhage, haematoma infection, pancytopenia. DACLIZUMAB dosage: 2MG/KG FIRST DOSE 24 HOURS PRE-TRANSPLANT AS PER PROTOCOL.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5568496-X
Physician from SPAIN reported DACLIZUMAB problem on Dec 14, 2007. Male patient, 55 years of age, weighting 182.5 lb, was diagnosed with immunosuppression and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: human polyomavirus infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, SULFAMETHOXAZOLE, RANITIDINE. Patient recovered.
Daclizumab Side Effects Report #5507967-9
DACLIZUMAB problem was reported by a Physician from SPAIN on Oct 22, 2007. Male patient, 61 years of age, weighting 151.2 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: angiopathy, cytomegalovirus test, pneumonia bacterial. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYCLOSPORINE, PREDNISONE, SIROLIMUS, AMLODIPINE, CARVEDILOL, RANITIDINE, ASPIRIN. Patient was hospitalized and became disabled. Patient recovered.
Daclizumab Side Effects Report #5511250-5
Physician from GERMANY reported DACLIZUMAB problem on Oct 31, 2007. Male patient, 34 years of age, weighting 160.9 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, diarrhoea, renal artery stenosis. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5520969-1
DACLIZUMAB problem was reported by a Physician from GERMANY on Nov 11, 2007. Male patient, 51 years of age, weighting 152.1 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, arterial haemorrhage, haematoma infection, pancytopenia. DACLIZUMAB dosage: 2MG/KG FIRST DOSE 24 HOURS PRE-TRANSPLANT AS PER PROTOCOL.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5525703-7
Physician from SPAIN reported DACLIZUMAB problem on Nov 15, 2007. Female patient, 57 years of age, weighting 133.8 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, peritonitis, respiratory tract infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS, PREDNISONE, PANTOPRAZOLE, FOLIC ACID. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5527937-4
DACLIZUMAB problem was reported by a Physician from GERMANY on Nov 21, 2007. Female patient, 64 years of age, weighting 134.5 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, urinary tract infection, urosepsis. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5527939-8
Physician from GERMANY reported DACLIZUMAB problem on Nov 21, 2007. Female patient, 57 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, cytomegalovirus infection, enteritis, haemorrhage subcutaneous, renal cyst, thrombosis. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5473223-0
DACLIZUMAB problem was reported by a Physician from UNITED STATES on Sept 21, 2007. Female patient, 33 years of age, weighting 164.2 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, adrenal suppression, eyelid oedema, haemoglobin decreased, hyperhidrosis, hyponatraemia, hypopituitarism, multiple sclerosis relapse, white blood cell count decreased. DACLIZUMAB dosage: unknown. During the same period patient was treated with BACLOFEN, TRIPHASIL, IBUPROFEN, ACETAMINOPHEN, REBIF, KALCIUM D, VITAMIN B CAP. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5478449-8
Health Professional from UNITED STATES reported DACLIZUMAB problem on Sept 26, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis, pneumonitis, pyrexia, rash. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYLOESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5492195-6
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on Oct 10, 2007. Female patient, 59 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, pneumonia, sepsis, septic shock. DACLIZUMAB dosage: unknown. During the same period patient was treated with TACROLIMUS, HYDROCORTISON, ERYTHROMYCIN. Patient died on 02/17/2006.
Daclizumab Side Effects Report #5442027-7
Physician from NETHERLANDS reported DACLIZUMAB problem on Aug 24, 2007. Male patient, 54 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct stenosis, hepatitis c. DACLIZUMAB dosage: unknown. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5454126-4
DACLIZUMAB problem was reported by a Physician from MEXICO on Sept 05, 2007. Female patient, 20 years of age, weighting 156.5 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, gastric ulcer. DACLIZUMAB dosage: 2 MG /KG FIRST DOSE 24 HOURS PRE-TRANSPLANT FOLLOWED BY 1 MG/KG EVERY TWO WEEKS FOR FOUR DOSES.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized and became disabled. Patient recovered.
Daclizumab Side Effects Report #5411260-2
Physician from NETHERLANDS reported DACLIZUMAB problem on Aug 01, 2007. Male patient, 57 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: liver transplant rejection, portal vein stenosis. DACLIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5411272-9
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on Aug 01, 2007. Female patient, 63 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: crossmatch incompatible. DACLIZUMAB dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5418226-7
Physician from TURKEY reported DACLIZUMAB problem on Aug 06, 2007. Male patient, 29 years of age, weighting 136.7 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: pneumonia. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS, CORTICOSTEROID NOS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5391419-3
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on July 11, 2007. Male patient, 67 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, cerebral hygroma. DACLIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5392092-0
Health Professional from UNITED STATES reported DACLIZUMAB problem on July 18, 2007. Female patient, weighting 196.2 lb, was diagnosed with multiple sclerosis, off label use and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central nervous system inflammation, condition aggravated, multiple sclerosis, nuclear magnetic resonance imaging brain abnormal, pleocytosis. DACLIZUMAB dosage: 1MG/KG 1X/MONTH IV. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5394143-6
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on July 11, 2007. Female patient, 63 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: crossmatch incompatible. DACLIZUMAB dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5397608-6
Health Professional from UNITED STATES reported DACLIZUMAB problem on July 17, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis, pneumonitis, pyrexia, rash. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5391419-3
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on July 11, 2007. Male patient, 67 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, cerebral hygroma. DACLIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5392092-0
Health Professional from UNITED STATES reported DACLIZUMAB problem on July 18, 2007. Female patient, weighting 196.2 lb, was diagnosed with multiple sclerosis, off label use and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central nervous system inflammation, condition aggravated, multiple sclerosis, nuclear magnetic resonance imaging brain abnormal, pleocytosis. DACLIZUMAB dosage: 1MG/KG 1X/MONTH IV. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5394143-6
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on July 11, 2007. Female patient, 63 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: crossmatch incompatible. DACLIZUMAB dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5397608-6
Health Professional from UNITED STATES reported DACLIZUMAB problem on July 17, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis, pneumonitis, pyrexia, rash. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5727486-4
DACLIZUMAB problem was reported by a Physician from UNITED STATES on Apr 28, 2008. Male patient was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, nausea, neutropenia, segmented hyalinising vasculitis, vomiting. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, ETANERCEPT, SIROLIMUS, TACROLIMUS, METHYLPREDNISOLONE, LOVENOX, PENTOXIFYLLINE. Patient recovered.
Daclizumab Side Effects Report #5727487-6
Physician from UNITED STATES reported DACLIZUMAB problem on Apr 28, 2008. Male patient was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: acne, anaemia, diarrhoea, dyslipidaemia, liver function test abnormal, mouth ulceration, nausea, necrobiosis lipoidica diabeticorum, neutropenia. DACLIZUMAB dosage: unknown. During the same period patient was treated with ETANERCEPT, SIROLIMUS, TACROLIMUS, LOVENOX, PENTOXIFYLLINE, VITAMIN A, VITAMIN B6. Patient recovered.
Daclizumab Side Effects Report #5727488-8
DACLIZUMAB problem was reported by a Physician from UNITED STATES on Apr 28, 2008. Female patient was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: neutropenia, pneumonia. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, ETANERCEPT, SIROLIMUS, TACROLIMUS, LOVENOX, PENTOXIFYLLINE, VITAMIN A. Patient recovered.
Daclizumab Side Effects Report #5727489-X
Physician from UNITED STATES reported DACLIZUMAB problem on Apr 28, 2008. Female patient was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, neutropenia, ovarian cyst. DACLIZUMAB dosage: unknown. During the same period patient was treated with INFLIXIMAB, SIROLIMUS, TACROLIMUS, ETANERCEPT, LOVENOX, PENTOXIFYLLINE, VITAMIN A. Patient recovered.
Daclizumab Side Effects Report #5727491-8
DACLIZUMAB problem was reported by a Physician from UNITED STATES on Apr 28, 2008. Male patient was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: neutropenia, squamous cell carcinoma of skin. DACLIZUMAB dosage: unknown. During the same period patient was treated with INFLIXIMAB, SIROLIMUS, TACROLIMUS, LOVENOX, PENTOXIFYLLINE, VITAMIN A, VITAMIN B6. Patient recovered.
Daclizumab Side Effects Report #5735032-4
Physician from SPAIN reported DACLIZUMAB problem on May 05, 2008. Male patient, weighting 187.4 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, congenital cystic kidney disease, cytomegalovirus infection, urinary tract infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5735040-3
DACLIZUMAB problem was reported by a Physician from SPAIN on May 05, 2008. Female patient, weighting 117.5 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: pyelonephritis acute, pyrexia, renal artery stenosis, varicella. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5736057-5
Physician from SPAIN reported DACLIZUMAB problem on May 07, 2008. Female patient, weighting 154.3 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, deep vein thrombosis. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, RANITIDINA, AMLODIPINO, GANCICLOVIR. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5738989-0
DACLIZUMAB problem was reported by a Physician from SPAIN on May 05, 2008. Male patient, weighting 143.3 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, cytomegalovirus infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYCLOSPORINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5698036-6
Physician from FRANCE reported DACLIZUMAB problem on Mar 31, 2008. Male patient, weighting 119.0 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: pyelonephritis. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5708250-9
DACLIZUMAB problem was reported by a Physician from SPAIN on Apr 10, 2008. Male patient, weighting 182.5 lb, was diagnosed with immunosuppression and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: human polyomavirus infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient recovered.
Daclizumab Side Effects Report #5342395-0
Physician from NETHERLANDS reported DACLIZUMAB problem on May 22, 2007. Male patient, 37 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: crohn's disease, hepatic artery thrombosis, renal failure. DACLIZUMAB dosage: unknown. During the same period patient was treated with CORTISONE ACETATE, URSO FALK, FRAGMIN, PANTOZOL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5342403-7
DACLIZUMAB problem was reported by a Physician from FRANCE on May 24, 2007. Female patient, 44 years of age, weighting 114.6 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: urinary tract infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYCLOSPORINE, CALCIUM CARBONATE, FUROSEMIDE, VITAMINE D, MAGNESIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5353764-7
Health Professional from UNITED STATES reported DACLIZUMAB problem on June 02, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis, pneumonitis, pyrexia, rash. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5358732-7
DACLIZUMAB problem was reported by a Physician from GERMANY on June 04, 2007. Female patient, 59 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: sepsis, wound dehiscence. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, HYDROCORTISONE INTRAVENOUS, ANTITHROMBIN III. Patient was hospitalized. Patient died on 09/28/2005.
Daclizumab Side Effects Report #5358853-9
Health Professional from UNITED STATES reported DACLIZUMAB problem on June 08, 2007. Female patient, 33 years of age, weighting 244.7 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, eosinophilia, interstitial lung disease, meningitis, pneumonitis, pyrexia, rash. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL, PERFALGAN. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5374245-0
DACLIZUMAB problem was reported by a Physician from SWEDEN on Mar 29, 2007. Male patient, 59 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE. Patient recovered.
Daclizumab Side Effects Report #5374269-3
Physician from CANADA reported DACLIZUMAB problem on Mar 29, 2007. Male patient, 53 years of age, weighting 162.7 lb, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: anastomotic complication, gastroenteritis viral, haematoma, renal failure acute, urinary tract infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5317038-2
DACLIZUMAB problem was reported by a Health Professional from UNITED STATES on May 01, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, interstitial lung disease, meningitis, pyrexia. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5317049-7
Health Professional from UNITED STATES reported DACLIZUMAB problem on Apr 24, 2007. Female patient, 38 years of age, weighting 138.9 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: breast cancer. DACLIZUMAB dosage: unknown. During the same period patient was treated with AMBIEN, IBUPROFEN, REBIF, QUININE SULPHATE, GABAPENTIN, ZANAFLEX, INTERFERON BETA. Patient recovered.
Daclizumab Side Effects Report #5317091-6
DACLIZUMAB problem was reported by a Physician from GERMANY on Apr 27, 2007. Male patient, 56 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISOLONE. Patient was hospitalized. Patient died on 12/27/2005.
Daclizumab Side Effects Report #5318023-7
Health Professional from UNITED STATES reported DACLIZUMAB problem on Apr 24, 2007. Female patient, 38 years of age, weighting 138.9 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: dermatitis psoriasiform, multiple sclerosis relapse, nuclear magnetic resonance imaging abnormal. DACLIZUMAB dosage: unknown. During the same period patient was treated with AMBIEN, IBUPROFEN, LIDOCAINE, INTERFERON BETA, LYRICA. Patient recovered.
Daclizumab Side Effects Report #5319054-3
DACLIZUMAB problem was reported by a Health Professional from UNITED STATES on May 02, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, cardio-respiratory arrest, erythema, erythema infectiosum, haemolysis, hepatitis toxic, hypotension, interstitial lung disease. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5320377-2
Physician from UNITED KINGDOM reported DACLIZUMAB problem on May 02, 2007. Female patient, 44 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal sepsis, ascites, atrial fibrillation, cellulitis, enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haematoma, haemoglobin decreased. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient died on 06/14/2005.
Daclizumab Side Effects Report #5327253-X
DACLIZUMAB problem was reported by a Physician from FRANCE on May 11, 2007. Male patient, 44 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: human herpesvirus 8 infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient recovered.
Daclizumab Side Effects Report #5328477-8
Physician from GERMANY reported DACLIZUMAB problem on May 07, 2007. Female patient, 59 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: sepsis, wound dehiscence. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, HYDROCORTISONE INTRAVENOUS, ANTITHROMBIN III. Patient was hospitalized. Patient died on 09/28/2005.
Daclizumab Side Effects Report #5338472-0
DACLIZUMAB problem was reported by a Health Professional from UNITED STATES on May 22, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, hypereosinophilic syndrome, interstitial lung disease, meningitis, pneumonitis, pyrexia, rash. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT, ETHINYL ESTRADIOL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5293398-6
Consumer or non-health professional from UNITED STATES reported DACLIZUMAB problem on Mar 31, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, alopecia, blood triglycerides increased, cardio-respiratory arrest, dysphagia, dysphonia, enterococcal infection, haematocrit decreased, haemoglobin decreased. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5296354-7
DACLIZUMAB problem was reported by a Physician from NORWAY on Apr 04, 2007. Male patient, 51 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: enterococcal infection, peritonitis, post procedural bile leak. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5297597-9
Physician from FRANCE reported DACLIZUMAB problem on Apr 04, 2007. Female patient, 56 years of age, was diagnosed with prophylaxis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, PIPERILLINE, BACTRIM. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5300888-6
DACLIZUMAB problem was reported by a Physician from FRANCE on Apr 06, 2007. Male patient, 43 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, blood culture positive, escherichia infection, pneumothorax, respiratory alkalosis, staphylococcal infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, GANCICLOVIR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5301858-4
Physician from FRANCE reported DACLIZUMAB problem on Apr 11, 2007. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus test. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5303177-9
DACLIZUMAB problem was reported by a Physician from FRANCE on Apr 11, 2007. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: hepatic haematoma, hepatitis c. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5303179-2
Physician from FRANCE reported DACLIZUMAB problem on Apr 11, 2007. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, cytomegalovirus infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5307601-7
DACLIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 33 years of age, weighting 242.5 lb, was diagnosed with multiple sclerosis and was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, anaemia, blood calcium decreased, blood phosphorus decreased, blood triglycerides increased, cardio-respiratory arrest, dysphagia, dysphonia, enterococcal infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with INTERFERON BETA, CLORAZEPATE, MICRODIOL, ORLISTAT. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5307624-8
Physician from FRANCE reported DACLIZUMAB problem on Apr 16, 2007. Male patient, 43 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, blood culture positive, body temperature increased, escherichia infection, pneumothorax, respiratory alkalosis, staphylococcal infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, GANCICLOVIR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5308444-0
DACLIZUMAB problem was reported by a Physician from SPAIN on Apr 15, 2007. Male patient, 65 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct necrosis, biliary tract disorder, post procedural infection. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #5311570-3
Physician from NORWAY reported DACLIZUMAB problem on Apr 18, 2007. Male patient, 51 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: enterococcal infection, peritonitis, post procedural bile leak. DACLIZUMAB dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.